Higher risk of dementia in English older individuals who are overweight or obese.
Obesity
body mass index
dementia
longitudinal study
Journal
International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871
Informations de publication
Date de publication:
01 08 2020
01 08 2020
Historique:
accepted:
22
05
2020
pubmed:
24
6
2020
medline:
28
4
2021
entrez:
24
6
2020
Statut:
ppublish
Résumé
Several risk factors contribute to dementia, but the role of obesity remains unclear. This study investigated whether increased body weight or central obesity were associated with a higher risk of developing dementia in a representative sample of older English adults. We studied 6582 participants from the English Longitudinal Study of Ageing (ELSA) who were aged ≥50 years and were dementia-free at baseline, that being either wave 1 (2002-2003) for study members who started at wave 1, or at either wave 2 (2004-2005) or 4 (2008-2009) for those who began the study as refreshment samples. Body mass index (BMI) was measured at baseline and categorized into normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2) and obese (≥30 kg/m2). Central obesity was defined as a waist circumference (WC) >88 cm for women and >102 cm for men. Cumulative incidence of dementia was ascertained based on physician-diagnosed dementia, an overall score >3.38 on the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and Hospital Episodes Statistics (HES) data at every ELSA wave from baseline until wave 8 (2016-2017). Cox proportional hazards models were used to assess the association between baseline BMI levels or abdominal obesity in relation to dementia incidence during the mean follow-up period of 11 years. From the overall sample, 6.9% (n = 453) of participants developed dementia during the follow-up period of maximum 15 years (2002-2017). Compared with participants with normal weight, those who were obese at baseline had an elevated risk of dementia incidence [hazard ratio (HR) = 1.34, 95% confidence interval (CI) 1.07-1.61] independent of sex, baseline age, apolipoprotein E-ε4 (APOE-ε4), education, physical activity, smoking and marital status. The relationship was slightly accentuated after additionally controlling for hypertension and diabetes (HR = 1.31, 95% CI 1.03-1.59). Women with central obesity had a 39% greater risk of dementia compared with non-central obese women (HR = 1.39, 95% CI 1.12-1.66). When compared with a normal BMI and WC group, the obese and high WC group had 28% (HR = 1.28, 95% CI 1.03-1.53) higher risk of dementia. Our results suggest that having an increased body weight or abdominal obesity are associated with increased dementia incidence. These findings have significant implications for dementia prevention and overall public health.
Sections du résumé
BACKGROUND
Several risk factors contribute to dementia, but the role of obesity remains unclear. This study investigated whether increased body weight or central obesity were associated with a higher risk of developing dementia in a representative sample of older English adults.
METHODS
We studied 6582 participants from the English Longitudinal Study of Ageing (ELSA) who were aged ≥50 years and were dementia-free at baseline, that being either wave 1 (2002-2003) for study members who started at wave 1, or at either wave 2 (2004-2005) or 4 (2008-2009) for those who began the study as refreshment samples. Body mass index (BMI) was measured at baseline and categorized into normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2) and obese (≥30 kg/m2). Central obesity was defined as a waist circumference (WC) >88 cm for women and >102 cm for men. Cumulative incidence of dementia was ascertained based on physician-diagnosed dementia, an overall score >3.38 on the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and Hospital Episodes Statistics (HES) data at every ELSA wave from baseline until wave 8 (2016-2017). Cox proportional hazards models were used to assess the association between baseline BMI levels or abdominal obesity in relation to dementia incidence during the mean follow-up period of 11 years.
RESULTS
From the overall sample, 6.9% (n = 453) of participants developed dementia during the follow-up period of maximum 15 years (2002-2017). Compared with participants with normal weight, those who were obese at baseline had an elevated risk of dementia incidence [hazard ratio (HR) = 1.34, 95% confidence interval (CI) 1.07-1.61] independent of sex, baseline age, apolipoprotein E-ε4 (APOE-ε4), education, physical activity, smoking and marital status. The relationship was slightly accentuated after additionally controlling for hypertension and diabetes (HR = 1.31, 95% CI 1.03-1.59). Women with central obesity had a 39% greater risk of dementia compared with non-central obese women (HR = 1.39, 95% CI 1.12-1.66). When compared with a normal BMI and WC group, the obese and high WC group had 28% (HR = 1.28, 95% CI 1.03-1.53) higher risk of dementia.
CONCLUSIONS
Our results suggest that having an increased body weight or abdominal obesity are associated with increased dementia incidence. These findings have significant implications for dementia prevention and overall public health.
Identifiants
pubmed: 32575116
pii: 5861491
doi: 10.1093/ije/dyaa099
pmc: PMC7660153
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1353-1365Subventions
Organisme : Department of Health
ID : PDF-2018-11-ST2-020
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG017644
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the International Epidemiological Association.
Références
J Nucl Cardiol. 2014 Aug;21(4):686-94
pubmed: 24810431
PLoS One. 2011 Mar 25;6(3):e17902
pubmed: 21464984
Brain Behav. 2017 Jun 23;7(8):e00745
pubmed: 28828207
Curr Atheroscler Rep. 2002 Nov;4(6):448-53
pubmed: 12361492
Bioinformatics. 2012 Jan 1;28(1):112-8
pubmed: 22039212
Lancet Neurol. 2006 Aug;5(8):713-20
pubmed: 16857578
J Alzheimers Dis. 2012;28(1):163-71
pubmed: 21965312
J Gerontol A Biol Sci Med Sci. 2009 Jan;64(1):103-9
pubmed: 19168781
Nature. 2012 May 16;485(7399):512-6
pubmed: 22622580
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Alzheimers Dement. 2015 Dec;11(12):1439-1451
pubmed: 26079416
Int J Epidemiol. 2013 Dec;42(6):1640-8
pubmed: 23143611
Neurology. 2009 Nov 10;73(19):1559-66
pubmed: 19901247
Obesity (Silver Spring). 2019 Nov;27(11):1883-1891
pubmed: 31689005
Alzheimers Dement. 2018 Nov;14(11):1406-1415
pubmed: 29763593
Arch Neurol. 2005 Oct;62(10):1556-60
pubmed: 16216938
Neurology. 2011 May 3;76(18):1568-74
pubmed: 21536637
Am J Epidemiol. 2015 May 1;181(9):672-9
pubmed: 25810457
Neurology. 2005 Sep 27;65(6):892-7
pubmed: 16186530
Lancet Diabetes Endocrinol. 2015 Jun;3(6):431-436
pubmed: 25866264
Obes Rev. 2008 May;9(3):204-18
pubmed: 18331422
Alzheimers Res Ther. 2016 Jul 30;8(1):23
pubmed: 27473681
Hum Brain Mapp. 2010 Mar;31(3):353-64
pubmed: 19662657
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
J Alzheimers Dis. 2019;70(s1):S87-S99
pubmed: 30689574
Alzheimers Dement. 2018 Feb;14(2):178-186
pubmed: 28943197
Physiol Behav. 2005 Dec 15;86(5):731-46
pubmed: 16263144
BMJ. 2017 Jul 5;358:j2856
pubmed: 28679494
PLoS One. 2012;7(6):e38268
pubmed: 22675535
Alzheimers Dement. 2017 Jan;13(1):38-44
pubmed: 27157826
Alzheimers Dement (Amst). 2017 Jun 20;8:165-178
pubmed: 28761927
PLoS Med. 2015 Jun 16;12(6):e1001841; discussion e1001841
pubmed: 26079503
Am J Clin Nutr. 2004 Mar;79(3):379-84
pubmed: 14985210
Age Ageing. 2007 Jan;36(1):23-9
pubmed: 17124253
JAMA Neurol. 2017 Oct 1;74(10):1246-1254
pubmed: 28783817
Neurology. 2009 May 19;72(20):1741-6
pubmed: 19451529
Alzheimers Dement. 2015 Jun;11(6):718-26
pubmed: 26045020
Lancet. 2014 Mar 15;383(9921):970-83
pubmed: 24269108
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81
pubmed: 8446617
Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):15-21
pubmed: 19057182
BMJ. 2005 Jun 11;330(7504):1360
pubmed: 15863436
Obes Res. 1998 Sep;6 Suppl 2:51S-209S
pubmed: 9813653
Alzheimers Dement. 2013 Nov;9(6):649-56
pubmed: 23474042
Obes Rev. 2011 May;12(5):e426-37
pubmed: 21348917
Cochrane Database Syst Rev. 2014 Apr 10;(4):CD010079
pubmed: 24719028
Arch Neurol. 2007 Mar;64(3):392-8
pubmed: 17353383
Lancet Neurol. 2016 Nov;15(12):1285-1294
pubmed: 27751558
Arch Intern Med. 2005 Feb 14;165(3):321-6
pubmed: 15710796